Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University.

John Fahy is a Professor of Medicine at the University of California San Francisco where he directs a clinical research lab focused on disease subtypes of asthma and new drug development.

Dr Sohal is Head of the Respiratory Translational Research Group at the University of Tasmania, Launceston, and internationally recognized leader in chronic lung disease. He is a respiratory disease adviser for the WHO. His research group is focused on discovering and identifying novel mechanisms that may act as exciting new therapeutic targets for treating chronic lung diseases, such as COPD, lung cancer, asthma-COPD overlap, pulmonary hypertension and ILDs. His lab is also home to investigations regarding effects of electronic smoking devices on lung health. He has been the Board Director TSANZ, and President TSANZ Tasmania Branch. Dr Sohal has been appointed Deputy Chair by the ERS for the Molecular Pathology and Functional Genomics Group.

Vanessa McDonald is a Professor of Nursing in the School of Nursing and Midwifery at the University of Newcastle, Australia and an honorary clinical nurse consultant in the Department of Respiratory and Sleep Medicine at John Hunter Hospital. She is Director of the Centres of Excellence in Treatable Traits, and the Hunter Medical Research Institute’s Asthma and Breathing Programme. Her research interests are centred around the development of innovative approaches to the management of chronic airway diseases. She is passionate about the development and implementation of personalised medicine strategies that place the person at the centre of health care delivery. Over >25 years Vanessa has developed expertise in respiratory clinical nursing practice and education, has contributed extensively to respiratory health advocacy and health policy and, has developed as an internationally recognised respiratory researcher. She is committed to committed to improving the health and quality of life of people with lung disease in our region and internationally, and to the mission of lung health.